<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201109037456N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2011-10-08</date_registration>
      <primary_sponsor>Ahvaz Jundishapour University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Aerobic Exercise Training on Abdominal Obesity and Lipid Profiles in Pre-menopausal Women.</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Aerobic Exercise Training on Abdominal Obesity and Lipid Profiles in Pre-menopausal Women.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2011-02-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>31</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/7907</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Prevention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Abdominal Obesity and Lipid Disorder.</hc_freetext>
      <i_freetext>Intervention 1: In the intervention group intervention, including aerobic endurance exercise three days a week for 30 sessions is that the duration of exercise sessions with each session 40 minutes in the first two weeks starting the last four weeks time will run out in 60 minutes  Exercise with fitness expert and researcher with the gym one morning and day clinic are advised to avoid consuming too much fatty food and more  diet,continue to daily routine. Intervention 2: In the control Group intervention  including consisted of advice to refrain from eating fatty Food and having daily routine activities and information to the researcher in order to participate in Regular sports.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Heydarpoor Parvin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ahvazdanshgah JONDISHAPOUR Nursing Midwifery</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 65 2237 8216</telephone>
        <email>heydarpoor@ajums.ac.ir</email>
        <affiliation>Jondishapour University of Ahvaz</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fayazi Sadighe</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ahvaz Jondishapur University School of Nursing Midwifery</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 61 1373 8395</telephone>
        <email>sadighe_fa@yahoo.com</email>
        <affiliation>Jondishapour UniversityMedical( Science University of Ahvaz)</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion Criteria:   1) abdominal circumference of 88 cm or waist-hip ratio of 0.85; 2) Not taking any drug, anti-fat, fiber and medicines such as lovastatin and wasting drug; 3) lack of regular physical activity during the past 6 months&#13;
Exclusion criteria:1) Failure to participate in sporting events and the absence of more than 3 sessions;&#13;
2) participate in sporting events sporting events other than the study; 3) Regular participation in sports more than one day a week</inclusion_criteria>
      <agemin>38 years</agemin>
      <agemax>52 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R00-R99</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the intervention group intervention, including aerobic endurance exercise three days a week for 30 sessions is that the duration of exercise sessions with each session 40 minutes in the first two weeks starting the last four weeks time will run out in 60 minutes  Exercise with fitness expert and researcher with the gym one morning and day clinic are advised to avoid consuming too much fatty food and more  diet,continue to daily routine.</i_keyword>
      <i_keyword>In the control Group intervention  including consisted of advice to refrain from eating fatty Food and having daily routine activities and information to the researcher in order to participate in Regular sports</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Abdominal Circumference. Timepoint: Before and After Intervention. Method of measurement: Tape and centimeter.</prim_outcome>
      <prim_outcome>Cholesterol. Timepoint: Before and After Intervention. Method of measurement: Mg/dl.</prim_outcome>
      <prim_outcome>Triglycirid. Timepoint: Before and After Intervention. Method of measurement: Mg/dl.</prim_outcome>
      <prim_outcome>High Density Lipoprotein. Timepoint: Before and After Intervention. Method of measurement: Mg/dl.</prim_outcome>
      <prim_outcome>Low Density Lipoprotein. Timepoint: Before and After Intervention. Method of measurement: Mg/dl.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Wheight. Timepoint: Before and After. Method of measurement: Kilograme(kg).</sec_outcome>
      <sec_outcome>Body mass Index. Timepoint: Before and After. Method of measurement: -.</sec_outcome>
      <sec_outcome>Waist-hip ratio. Timepoint: Before and After. Method of measurement: -.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz Jundishapour University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2011-01-30</approval_date>
        <contact_name>Ahvaz University of Medical Sciences</contact_name>
        <contact_address>Ahvaz.Golstan St. Ahvaz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
